Copy
PrePex Newsletter #13, March 2016
View this email in your browser

Special Announcement: 
PrePexTM Pre- Qualified For Use in Males Aged 13+
by the World Health Organization
 
Dear Friends, 
 
We are pleased to inform you that the World Health Organization (WHO) has expanded the intended use of the currently prequalified PrePexTM device to include adolescents aged 13 years and above. Effective immediately, the PrePexTM device can be offered for adult and adolescent males in the 14 priority countries in South and East Africa.  On 31 May 2013, PrePexTM was the first male circumcision device to receive WHO prequalification.
 
Circ MedTech's CEO, Eddy Horowitz said: "The expanded use of PrePexTM for younger ages will sustain Voluntary Medical Male Circumcision (VMMC) programs in the 14 Sub-Saharan Africa priority countries and will serve the new UNAIDS goal of an additional 27 Million male circumcisions by the year 2020."

Circ MedTech Ltd. is in the advanced stages of adapting PrePex™ technology for use with infants and children, thus offering safe male circumcision services to all ages, worldwide.

To date, more than 125,000 PrePex™ procedures have been conducted in 12 countries, namely: Botswana, Kenya, Lesotho, Malawi, Rwanda, South Africa, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe and Indonesia. More than 11 national Training Centers are located across Africa, training local healthcare professionals.

Offering an efficient non-surgical procedure, minimal discomfort, no loss of working days and high acceptability rates, PrePex™ - endorsed by Bill Gates and world leaders - has proved its ability to significantly increase demand among men and boost the scale-up of male circumcision programs in Sub-Saharan Africa. 

Thank you for your support and collaboration. Together we can help bring an end to AIDS! 

  Sincerely Yours, 

The PrePex Team
For more PrePex updates:
Facebook
Facebook
Twitter
Twitter
YouTube
YouTube
LinkedIn
LinkedIn
Website
Website
Email
Email
Share
Tweet
Forward
Share
©2016 Circ MedTech Ltd., all rights reserved